about
CRISPR-Cas9 as a Powerful Tool for Efficient Creation of Oncolytic VirusesBridging academic science and clinical research in the search for novel targeted anti-cancer agentsOncolytic Replication of E1b-Deleted AdenovirusesOncolytic adenovirus research evolution: from cell-cycle checkpoints to immune checkpointsThe case for conducting first-in-human (phase 0 and phase 1) clinical trials in low and middle income countries.Cultivating regenerative medicine innovation in China.European attitudes on the regulation of modern biotechnology and their consequences.Science-based health innovation in sub-Saharan Africa.Turning science into health solutions: KEMRI's challenges as Kenya's health product pathfinder.BRIC's Growing Share of Global Health Spending and Their Diverging Pathways.Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective studyChanges in the intestinal absorption mechanism of icariin in the nanocavities of cyclodextrins.Emergence of biopharmaceutical innovators in China, India, Brazil, and South Africa as global competitors and collaboratorsMentoring, training and support to global health innovators: a scoping review.Obstacles and opportunities in Chinese pharmaceutical innovation.Oncolytic viruses in the treatment of cancer: a review of current strategies.Global health. Stagnant health technologies in Africa.Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s).A survey of South-North health biotech collaboration.Life sciences venture capital in emerging markets.Innovative drugs and vaccines in China, India and Brazil.Medical device market in China.Histone deacetylase inhibitor trichostatin A sensitises cisplatin-resistant ovarian cancer cells to oncolytic adenovirus.South-South entrepreneurial collaboration in health biotech
P2860
Q26766798-68DF0BC1-5FC6-4B45-8FE7-B32B12BDEDEDQ26771396-0221C4D8-BD8F-4D6F-8DB5-954C2FCB0690Q26777406-716931B2-2347-4ECE-8F4C-E5F8B92D7B08Q28083515-6BB5E44B-C38D-450C-AECA-C2219632AE64Q34050959-8E11B232-E24F-4929-9DF7-C6549A97E531Q34091435-19C73CC6-A2A8-4066-83B7-EA4AE9807BECQ34262350-65B11D4E-A7D0-4F14-8350-F00BACF341B4Q34404295-229FE87F-801D-4EB7-A994-C9E5FC536E0BQ34404303-4C5D05ED-8E0E-4EFA-9869-C505E57EB130Q35575110-C8DC8D8F-7795-47C4-A69E-E8CB01A2D4E1Q36028552-31A67716-5D06-412E-9D61-A37952EDB109Q36161028-10627A1E-69D4-45F4-8D21-5C5A7E4529EDQ36178930-684E2011-16C3-4EBB-B33D-7E40F75EA9B8Q36647823-0AA41473-7E31-41DC-8E81-F965662A79AAQ37720874-BDD4E112-8E5F-4267-B20A-F9CA32C3BA1BQ38020107-945D4F03-0625-498B-9FBE-BF41FF61AB89Q39464384-F9EEABB9-914B-471A-BE22-DE28644E0ACEQ40206138-EECFF151-C834-47FE-8AB8-237A07E00052Q43716936-267AA2DA-CE3A-4386-B7BB-6A952771D0A9Q44094283-F5D38B31-8E9F-48F0-A7FD-1572A23E700FQ44891323-2A1023B1-1645-442C-9993-2A069B81F14BQ49153321-2E73CC0F-A870-4F26-8079-61D96ABCB76EQ55262321-02056374-5BFE-4825-9F0E-51669C1E3E49Q57186469-9A2D54E5-7F51-4295-860F-5AA785165678
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Chinese health biotech and the billion-patient market.
@ast
Chinese health biotech and the billion-patient market.
@en
Chinese health biotech and the billion-patient market.
@nl
type
label
Chinese health biotech and the billion-patient market.
@ast
Chinese health biotech and the billion-patient market.
@en
Chinese health biotech and the billion-patient market.
@nl
prefLabel
Chinese health biotech and the billion-patient market.
@ast
Chinese health biotech and the billion-patient market.
@en
Chinese health biotech and the billion-patient market.
@nl
P2093
P2860
P356
P1433
P1476
Chinese health biotech and the billion-patient market.
@en
P2093
Abdallah S Daar
Alysha F Shore
Joshua K Ramjist
Peter A Singer
Rahim Rezaie
Sara Al-Bader
Sarah E Frew
Stephen M Sammut
P2860
P2888
P356
10.1038/NBT0108-37
P577
2008-01-01T00:00:00Z
P5875
P6179
1012067970